Cannabis Companies: House’s SAFE Act Vote A Milestone

A vote in Congress to ease banking restrictions on cannabis companies is being praised for the possibility the legislation could make operating in the nascent industry much easier and more fair, and for the signal it sends that marijuana is moving toward establishment acceptability. Continue reading “Cannabis Companies: House’s SAFE Act Vote A Milestone”

What Zynerba’s Flop Means For CBD Therapies And GW Pharmaceuticals

Shares of Zynerba Pharmaceuticals Inc (NASDAQ: ZYNE) lost more than 58 percent of their value Monday morning after the company reported disappointing results from its phase 2 STAR 1 clinical trial Continue reading “What Zynerba’s Flop Means For CBD Therapies And GW Pharmaceuticals”

GW Pharma Takes A Step Toward Diversifying

Being a one-trick pony can always prove risky. This rationale seems to have dawned on GW Pharmaceuticals PLC- ADR (NASDAQ:GWPH), a biopharmaceutical company specializing in prescription cannabinoid medicine. Continue reading “GW Pharma Takes A Step Toward Diversifying”

Marijuana Legalization Around The World: Who’s Next?

On Tuesday, Benzinga published an article where cannabis industry experts shared their thoughts regarding the legalization of recreational marijuana in Canada. But, America’s hat is not the only country considering legalization measures. Continue reading “Marijuana Legalization Around The World: Who’s Next?”